A new bill introduced in the U.S. House of Representatives today aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.
Cancer patients and survivors continue to experience potentially serious health care delays during the pandemic, and tomorrow leadership across Oklahoma will shine a light on the disparities affecting Native Americans’ cancer outcomes.
Tobacco is the leading cause of preventable death nationwide and is linked to at least 13 types of cancer. Reducing use of this deadly product is critical to our mission to end suffering and death from this disease. Given the industry’s known targeting of people with lower incomes, Black communities, American Indians, youth, and LGBTQ individuals, tobacco control efforts are also crucial to reduce cancer disparities in this country.
The American Cancer Society Cancer Action Network (ACS CAN) today released a report detailing the costs of treating cancer, specifically out-of-pocket costs typical cancer patients face. The report found U.S. cancer patients in 2018 spent $5.6 billion in out-of-pocket costs for cancer treatment
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN por sus siglas en inglés) publicó hoy un informe que detalla los costos del tratamiento de cáncer, específicamente los gastos de bolsillo que enfrentan los típicos pacientes de cáncer.
Legislation introduced in the U.S. Senate today aims to improve access to quality health care for communities of color and decrease health disparities, such as those resulting in a disproportionate number of COVID-19 cases and deaths in these communities. Additionally, it offers a path to increase the federal tobacco tax, including tax parity on other tobacco products like e-cigarettes, and improve access to lifesaving cessation services in Medicaid and private health plans.
The American Cancer Society Cancer Action Network (ACS CAN) released new policy recommendations today to increase uptake of biomarker testing and advance the use of precision medicine in cancer care. The recommendations follow the release of new data that shows access is not keeping up with innovation when it comes to biomarker testing.
A statement from Gary M. Reedy, CEO of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) follows on the death of Supreme Court Justice, Ruth Bader Ginsburg from complications from pancreatic cancer
Kathy Ottele of Salem was named the State Lead Ambassador (SLA) of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her dedicated volunteer and advocacy efforts to help make cancer a national priority. This annual award is presented to a lead ACS CAN volunteer who has demonstrated exemplary leadership while advocating for ACS CAN’s priority areas of cancer-related public policy.